Temasek - Massinvestor Venture Capital and Private Equity Database

VC Temasek

http://www.temasek.com.sg/

Office Locations:

23 King Street
London, SW1Y 6QY
United Kingdom
Phone: 44-20-7747-5040

Get all office locations for this firm with a National Database subscription or New York Database subscription.

Stages:

Growth

Industries:

Communications & Networking

Consumer Products & Services

Energy & Clean Tech

Financial Services

Life Sciences & Healthcare

Media & Digital Media

Real Estate & Construction

Transportation & Distribution

Description:

Incorporated in 1974, Temasek is an investment company based in Singapore. Supported by 11 offices globally, Temasek owns a S$242 billion portfolio as at 31 March 2016, mainly in Singapore and Asia. Temasek's investment themes center on: Transforming Economies; Growing Middle Income Populations; Deepening Comparative Advantages; and Emerging Champions. Its portfolio covers a broad spectrum of industries: financial services; telecommunications, media and technology; transportation and industrials; life sciences, consumer and real estate; as well as energy and resources. Temasek is governed by the provisions of the Singapore Company Act.

Investment Firm Key

   VC = Venture Capital
   PE = Private Equity
   A = Angel
   I = Incubator
   MB = Merchant Bank
   VD = Venture Debt
   FI = Family Investment Office
   FOF = Fund of Funds
   ED = Economic Development Office
   TT = Technology Transfer Office
   CVC = Corporate Venture Capital
   SEC = Secondary Purchaser
   HF = Hedge Fund/Mutual Fund

COMPANY STAGE	REVENUE
Venture Capital
Seed Stage (includes "pre-seed," or concept stage)	No Revenue
Early Stage	Minimal Revenue
Growth Stage (also called Mid-stage)	$2M-$7M
Expansion Stage (also called Late-stage)	$7M and greater
Private Equity
Lower Middle Market	$10M-$249M
Middle Market	$250M-$499M
Upper Middle Market	$500M-$1B
Large Cap	>$1B

Click Here for a
FREE DEMO
of the #1 VC & PE
Database
>4,000 Firms
>18,000 Partners
>30,000 Portfolio
companies

Investment Team:

Name	Title	Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
Benoit Valentin	Senior Managing Director
Gregory Curl	President
Ho Ching	Executive Director & CEO
Lee Theng Kiat	Executive Director & CEO
Luigi Feola	Senior Managing Director

Recent Funding Events (trailing 12 months):

Date	Name	State	Amount	Stage
08/14/2018	Orchard Therapeutics	MA	$150,000,000	Series C
08/09/2018	Akili Interactive		$13,000,000	Series C
07/29/2018	Flywire	MA	$100,000,000	Series D
07/27/2018	ClassPass	NY	$85,000,000	Series D
06/11/2018	Claroty	NY	$60,000,000	Series B
05/23/2018	Iora Health	MA	$100,000,000	Series E
05/09/2018	Akili Interactive Labs	MA	$55,000,000	Series C
04/03/2018	Impossible Foods	CA	$114,000,000
03/05/2018	C2FO	KS	$100,000,000
03/01/2018	Perfect Day	CA	$24,700,000	Series A
02/28/2018	Viela Bio	MD	$250,000,000	Series A
02/17/2018	Harry's	NY	$112,000,000	Series D
01/25/2018	Stem	CA	$80,000,000	Series D
01/22/2018	Bolt Threads	CA	$123,000,000	Series D
01/02/2018	PEAR Therapeutics	MA	$50,000,000	Series B
11/30/2017	Farmers Business Network	CA	$110,000,000	Series D
11/16/2017	Poshmark	CA	$87,500,000	Series D
11/15/2017	Arterys	CA	$30,000,000	Series B
10/17/2017	Magic Leap	FL	$502,000,000	Series D
10/10/2017	Bill.com	CA	$100,000,000